Clinical Trials Browser

Phase 3 × Autoimmune Diseases × 30 days × Clear all

NCT07039916 2026-03-06

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Phase 3 Recruiting

Autoimmune Diseases, Myasthenia Gravis